Cargando…
Genomic testing in voluntary workplace wellness programs in the US: Evidence and challenges
BACKGROUND: Workplace genetic and/or genomic testing (wGT) is one of many options that employers can offer within the scope of voluntary workplace wellness programs, though we know little about how many employers are offering this benefit, or what kinds of testing are included. METHODS: Our landscap...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655502/ https://www.ncbi.nlm.nih.gov/pubmed/37592452 http://dx.doi.org/10.1002/mgg3.2245 |
_version_ | 1785136839056687104 |
---|---|
author | Cohn, Betty Ryan, Kerry A. Hendy, Katherine Callahan, Katherine Roberts, J. Scott Spector‐Bagdady, Kayte Mathews, Debra J. H. |
author_facet | Cohn, Betty Ryan, Kerry A. Hendy, Katherine Callahan, Katherine Roberts, J. Scott Spector‐Bagdady, Kayte Mathews, Debra J. H. |
author_sort | Cohn, Betty |
collection | PubMed |
description | BACKGROUND: Workplace genetic and/or genomic testing (wGT) is one of many options that employers can offer within the scope of voluntary workplace wellness programs, though we know little about how many employers are offering this benefit, or what kinds of testing are included. METHODS: Our landscaping review sought to discover the prevalence and distribution of wGT within voluntary wellness programs among U.S. companies using three approaches: (1) analysis of publicly available information; (2) national surveys; and (3) interviews with company representatives. RESULTS: In total, 50/420 (11.9%) companies we investigated had publicly available data suggesting that they offer wGT to their employees. Survey data weighted to be representative of the type and distribution of U.S. companies suggest that ~1% of U.S. companies offer wGT to their employees. CONCLUSION: Our research found little evidence of broad uptake of wGT among U.S. companies, though information gathering was challenging. |
format | Online Article Text |
id | pubmed-10655502 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-106555022023-08-17 Genomic testing in voluntary workplace wellness programs in the US: Evidence and challenges Cohn, Betty Ryan, Kerry A. Hendy, Katherine Callahan, Katherine Roberts, J. Scott Spector‐Bagdady, Kayte Mathews, Debra J. H. Mol Genet Genomic Med Original Articles BACKGROUND: Workplace genetic and/or genomic testing (wGT) is one of many options that employers can offer within the scope of voluntary workplace wellness programs, though we know little about how many employers are offering this benefit, or what kinds of testing are included. METHODS: Our landscaping review sought to discover the prevalence and distribution of wGT within voluntary wellness programs among U.S. companies using three approaches: (1) analysis of publicly available information; (2) national surveys; and (3) interviews with company representatives. RESULTS: In total, 50/420 (11.9%) companies we investigated had publicly available data suggesting that they offer wGT to their employees. Survey data weighted to be representative of the type and distribution of U.S. companies suggest that ~1% of U.S. companies offer wGT to their employees. CONCLUSION: Our research found little evidence of broad uptake of wGT among U.S. companies, though information gathering was challenging. John Wiley and Sons Inc. 2023-08-17 /pmc/articles/PMC10655502/ /pubmed/37592452 http://dx.doi.org/10.1002/mgg3.2245 Text en © 2023 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Cohn, Betty Ryan, Kerry A. Hendy, Katherine Callahan, Katherine Roberts, J. Scott Spector‐Bagdady, Kayte Mathews, Debra J. H. Genomic testing in voluntary workplace wellness programs in the US: Evidence and challenges |
title | Genomic testing in voluntary workplace wellness programs in the US: Evidence and challenges |
title_full | Genomic testing in voluntary workplace wellness programs in the US: Evidence and challenges |
title_fullStr | Genomic testing in voluntary workplace wellness programs in the US: Evidence and challenges |
title_full_unstemmed | Genomic testing in voluntary workplace wellness programs in the US: Evidence and challenges |
title_short | Genomic testing in voluntary workplace wellness programs in the US: Evidence and challenges |
title_sort | genomic testing in voluntary workplace wellness programs in the us: evidence and challenges |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655502/ https://www.ncbi.nlm.nih.gov/pubmed/37592452 http://dx.doi.org/10.1002/mgg3.2245 |
work_keys_str_mv | AT cohnbetty genomictestinginvoluntaryworkplacewellnessprogramsintheusevidenceandchallenges AT ryankerrya genomictestinginvoluntaryworkplacewellnessprogramsintheusevidenceandchallenges AT hendykatherine genomictestinginvoluntaryworkplacewellnessprogramsintheusevidenceandchallenges AT callahankatherine genomictestinginvoluntaryworkplacewellnessprogramsintheusevidenceandchallenges AT robertsjscott genomictestinginvoluntaryworkplacewellnessprogramsintheusevidenceandchallenges AT spectorbagdadykayte genomictestinginvoluntaryworkplacewellnessprogramsintheusevidenceandchallenges AT mathewsdebrajh genomictestinginvoluntaryworkplacewellnessprogramsintheusevidenceandchallenges AT genomictestinginvoluntaryworkplacewellnessprogramsintheusevidenceandchallenges |